
    
      This study was randomised, two-treatment, two-period, two-sequence, single-dose, crossover
      bioavailability study planned on 60 healthy, adult, subjects under fasting conditions. 60
      subjects were enrolled and 55 subjects completed all the periods of the study. Both periods
      were separated by a washout period of fourteen days A total of Sixty (60) subjects were
      enrolled in this study; 55 completed the study.
    
  